PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease

Michael Mahler, Dimitrios P Bogdanos, Polychronis Pavlidis, Marvin J Fritzler, Elena Csernok, Jan Damoiseaux, Chelsea Bentow, Zakera Shums, Alastair Forbes, Gary L Norman

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

We determined if PR3-ANCA is a biomarker that differentiates ulcerative colitis (UC) from Crohn's disease (CrD).
Original languageEnglish
Pages (from-to)267-73
Number of pages7
JournalClinica Chimica Acta
Volume424
DOIs
Publication statusPublished - 23 Sep 2013

Keywords

  • Adult
  • Aged
  • Antibodies, Antineutrophil Cytoplasmic
  • Biological Markers
  • Colitis, Ulcerative
  • Crohn Disease
  • Diagnosis, Differential
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Luminescent Measurements
  • Male
  • Middle Aged
  • ROC Curve
  • Severity of Illness Index

Cite this